29 related articles for article (PubMed ID: 38513896)
21. Hydroxychloroquine interaction with phosphoinositide 3-kinase modulates prostate cancer growth in bone microenvironment: In vitro and molecular dynamics based approach.
Abdullah KM; Sharma G; Qais FA; Khan I; Takkar S; Kaushal JB; Kanchan RK; Sarwar T; Chakravarti B; Siddiqui JA
Int J Biol Macromol; 2024 May; 266(Pt 1):130912. PubMed ID: 38513896
[TBL] [Abstract][Full Text] [Related]
22. Bone-targeting agents in prostate cancer.
Suzman DL; Boikos SA; Carducci MA
Cancer Metastasis Rev; 2014 Sep; 33(2-3):619-28. PubMed ID: 24398856
[TBL] [Abstract][Full Text] [Related]
23. Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer.
Pungsrinont T; Kallenbach J; Baniahmad A
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681745
[TBL] [Abstract][Full Text] [Related]
24. The PI3K/AKT pathway in the pathogenesis of prostate cancer.
Chen H; Zhou L; Wu X; Li R; Wen J; Sha J; Wen X
Front Biosci (Landmark Ed); 2016 Jun; 21(5):1084-91. PubMed ID: 27100493
[TBL] [Abstract][Full Text] [Related]
25. Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer.
Lee CH; Decker AM; Cackowski FC; Taichman RS
Cell Biol Toxicol; 2020 Apr; 36(2):115-130. PubMed ID: 31250347
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases.
Hardaway AL; Herroon MK; Rajagurubandara E; Podgorski I
Cancer Metastasis Rev; 2014 Sep; 33(2-3):527-43. PubMed ID: 24398857
[TBL] [Abstract][Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
